172@29@16@167!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php

Network18 Presents

partnered by

  • Galaxy Note20 | 20 Ultra
Moneycontrol
SENSEX NIFTY

Network18 Presents

  • partnered by
  • Galaxy Note20 | 20 Ultra
you are here:

Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals

BSE Live

Aug 14, 14:51
1046.00 -31.55 (-2.93%)
Volume
AVERAGE VOLUME
5-Day
42,968
10-Day
67,198
30-Day
45,961
18,986
  • Prev. Close

    1077.55

  • Open Price

    1075.10

  • Bid Price (Qty.)

    1044.05 (9)

  • Offer Price (Qty.)

    1045.80 (9)

NSE Live

Aug 14, 14:51
1044.05 -33.90 (-3.14%)
Volume
AVERAGE VOLUME
5-Day
620,443
10-Day
705,413
30-Day
621,255
399,046
  • Prev. Close

    1077.95

  • Open Price

    1083.70

  • Bid Price (Qty.)

    1044.00 (142)

  • Offer Price (Qty.)

    1044.05 (21)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of Alembic Pharmaceuticals (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 4,491.97 3,806.61 3,124.67 3,130.92 3,162.39  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.63 29.46 0.00  
Revenue From Operations [Net] 4,491.97 3,806.61 3,124.04 3,101.46 3,162.39  
Total Operating Revenues 4,605.75 3,934.68 3,130.18 3,105.15 3,165.98  
Other Income 4.94 9.38 7.03 2.02 7.27  
Total Revenue 4,610.69 3,944.06 3,137.21 3,107.17 3,173.25  
EXPENSES  
Cost Of Materials Consumed 979.05 850.04 725.75 703.87 653.94  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Employee Benefit Expenses 906.44 746.69 622.81 558.83 472.85  
Finance Costs 27.16 18.41 3.40 5.23 5.43  
Depreciation And Amortisation Expenses 157.32 115.23 105.46 82.97 72.21  
Other Expenses 1,436.90 1,321.71 978.72 1,072.94 905.32  
Total Expenses 3,567.21 3,194.74 2,595.95 2,578.07 2,236.94  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,043.48 749.32 541.26 529.10 936.31  
Exceptional Items -43.65 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 999.83 749.32 541.26 529.10 936.31  
Tax Expenses-Continued Operations  
Current Tax 204.57 178.14 123.61 122.40 198.75  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -4.30 -17.29 -2.16 -0.21 17.37  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 199.18 156.75 120.35 122.19 216.12  
Profit/Loss After Tax And Before ExtraOrdinary Items 800.65 592.57 420.91 406.91 720.19  
Profit/Loss From Continuing Operations 800.65 592.57 420.91 406.91 720.19  
Profit/Loss For The Period 800.65 592.57 420.91 406.91 720.19  
Minority Interest 28.12 1.08 -0.19 0.09 0.00  
Consolidated Profit/Loss After MI And Associates 828.82 584.37 412.63 403.17 720.04  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 44.00 31.00 22.00 21.00 38.00  
Diluted EPS (Rs.) 44.00 31.00 22.00 21.00 38.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 325.97 90.91 75.41 75.41 79.41  
Tax On Dividend 0.00 0.00 15.35 15.35 0.00  
Source : Dion Global Solutions Limited